Literature DB >> 8391722

Disseminated Strongyloides stercoralis infection.

W G Simpson1, D C Gerhardstein, J R Thompson.   

Abstract

A case of disseminated S stercoralis is an immunosuppressed patient manifested with diarrhea, a rash, and progressive respiratory insufficiency. The parasites were eradicated with thiabendazole despite continued steroid therapy, and the patient survived the hospitalization. The characteristics of S stercoralis allow it to be harbored within a host for prolonged periods of time, only to disseminate once cell-mediated immunity is suppressed. A diagnosis of strongyloidiasis should be considered in an immunocompromised patient with a petechial rash. Prompt diagnosis and initiation of thiabendazole therapy provides the greatest opportunity for patient survival. Secondary bacterial infections should be aggressively sought. Mortality from disseminated strongyloidiasis approaches 80%.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8391722     DOI: 10.1097/00007611-199307000-00022

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  12 in total

1.  Strongyloides infection in a cardiac transplant recipient: making a case for pretransplantation screening and treatment.

Authors:  Inderpreet S Grover; Rene Davila; Charu Subramony; Sumanth R Daram
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-11

Review 2.  Neuroparasitic infections: nematodes.

Authors:  M D Walker; J R Zunt
Journal:  Semin Neurol       Date:  2005-09       Impact factor: 3.420

3.  Strongyloides hyperinfection syndrome following resection of meningioma.

Authors:  Clifford Leigh Shelton; Timothy Smith; Konstantina Karabatsou; Katherine Ajdukiewicz
Journal:  BMJ Case Rep       Date:  2012-06-15

Review 4.  Parasitic central nervous system infections in immunocompromised hosts.

Authors:  Melanie Walker; Joseph R Zunt
Journal:  Clin Infect Dis       Date:  2005-03-02       Impact factor: 9.079

5.  Update on strongyloidiasis in the immunocompromised host.

Authors:  Luis A Marcos; Angélica Terashima; Marco Canales; Eduardo Gotuzzo
Journal:  Curr Infect Dis Rep       Date:  2011-02       Impact factor: 3.725

6.  A Case of Bacteremia and Meningitis Associated with Piperacillin-Tazobactam Nonsusceptible, Ceftriaxone Susceptible Escherichia coli during Strongyloides Hyperinfection in an Immunocompromised Host.

Authors:  Santosh Dahal; Jeffrey Lederman; Jesse Berman; Marius Viseroi; Stephen Jesmajian
Journal:  Case Rep Infect Dis       Date:  2017-11-22

Review 7.  Unexpected hosts: imaging parasitic diseases.

Authors:  Pablo Rodríguez Carnero; Paula Hernández Mateo; Susana Martín-Garre; Ángela García Pérez; Lourdes Del Campo
Journal:  Insights Imaging       Date:  2016-11-23

Review 8.  Severe strongyloidiasis: a systematic review of case reports.

Authors:  Dora Buonfrate; Ana Requena-Mendez; Andrea Angheben; Jose Muñoz; Federico Gobbi; Jef Van Den Ende; Zeno Bisoffi
Journal:  BMC Infect Dis       Date:  2013-02-08       Impact factor: 3.090

9.  Disseminated strongyloidiasis complicating glioblastoma therapy: a case report.

Authors:  Dawit Aregawi; David Lopez; Mark Wick; W Michael Scheld; David Schiff
Journal:  J Neurooncol       Date:  2009-03-31       Impact factor: 4.506

10.  Development of a rapid serological assay for the diagnosis of strongyloidiasis using a novel diffraction-based biosensor technology.

Authors:  Brian J Pak; Fabio Vasquez-Camargo; Evgeniya Kalinichenko; Peter L Chiodini; Thomas B Nutman; Herbert B Tanowitz; Isabel McAuliffe; Patricia Wilkins; Paul T Smith; Brian J Ward; Michael D Libman; Momar Ndao
Journal:  PLoS Negl Trop Dis       Date:  2014-08-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.